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Introduction
Multiple sclerosis (MS) is primarily a disease of 
adulthood, with peak incidence between 30 and 
50 years of age,1–3 although MS in children has 
recently become increasingly studied. Pediatric-onset 
multiple sclerosis (PoMS) cases are a small propor-
tion (3%–10%) of all those diagnosed with MS.4 
While etiological risk factors identified in studies of 
adult-onset MS5,6 have also been shown to be associ-
ated with PoMS,7,8 more research is needed to inform 
on the etiology of MS in pediatric populations. PoMS 
provides a unique opportunity to study MS etiology, 
relative to adults, because cases are younger, and thus, 
(1) key exposures occur closer in time to MS onset 
and (2) the time period in which to search for risk fac-
tors is shorter. In addition, studies suggest that MS 
risk is determined in childhood and early 
adolescence.9–15
A common methodological problem faced in PoMS 
epidemiological studies is small sample sizes. 
Because PoMS is rare, the number of cases that can be 
obtained in individual studies is low and requires long 
periods of time to accrue to have sufficient statistical 
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Abstract
Background: While studying the etiology of multiple sclerosis (MS) in children has several method-
ological advantages over studying etiology in adults, studies are limited by small sample sizes.
Objective: Using a rigorous methodological process, we developed the Pediatric MS Tool-Kit, a mea-
surement framework that includes a minimal set of core variables to assess etiological risk factors.
Methods: We solicited input from the International Pediatric MS Study Group to select three risk fac-
tors: environmental tobacco smoke (ETS) exposure, sun exposure, and vitamin D intake. To develop the 
Tool-Kit, we used a Delphi study involving a working group of epidemiologists, neurologists, and content 
experts from North America and Europe.
Results: The Tool-Kit includes six core variables to measure ETS, six to measure sun exposure, and six 
to measure vitamin D intake. The Tool-Kit can be accessed online (www.maelstrom-research.org/mica/
network/tool-kit).
Conclusion: The goals of the Tool-Kit are to enhance exposure measurement in newly designed pediatric 
MS studies and comparability of results across studies, and in the longer term to facilitate harmonization 
of studies, a methodological approach that can be used to circumvent issues of small sample sizes. We 
believe the Tool-Kit will prove to be a valuable resource to guide pediatric MS researchers in developing 
study-specific questionnaire
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power to precisely estimate main effects or to explore 
interaction between risk factors. Harmonization, a 
methodology used to combine data collected in multi-
ple studies, provides a potential solution to small sam-
ple sizes. The methodology used for harmonization 
focuses on the use of a common set of core variables, 
which serve as a framework to conduct pooled 
analyses.16
We developed the Pediatric MS Tool-Kit (Tool-Kit) 
for pediatric MS researchers to design study-specific 
questionnaires based on variables which (1) have 
been selected using a rigorous methodological pro-
cess, (2) enhance comparability of results across stud-
ies, and (3) are amenable to future harmonized 
analyses. This paper describes the methodology that 
was used to develop the Tool-Kit and provides an 
overview of how the Tool-Kit can be used in pediatric 
MS research.
Methods
We solicited input from the International Pediatric 
MS Study Group (IPMSSG)17 using an online survey 
to select three risk factors. We searched PubMed in 
March 2013 (search date range: 2000–2013) for epi-
demiological studies that examined the etiology of 
MS to generate a list of etiological factors, which was 
then filtered using the following predefined criteria: 
(1) an association was found with the risk of MS, in at 
least one high-quality study; (2) the timing of expo-
sure is relevant to PoMS; and (3) the risk factor can be 
measured using a self-report questionnaire. The sur-
vey was distributed in May 2014 to 138 IPMSSG 
members. Respondents were asked to report whether, 
in their view, each risk factor was (1) a priority, (2) 
important, but not a priority, (3) not important for 
future research, or (4) I don’t have an opinion.
A systematic review of measurement property studies 
was conducted to summarize the available evidence 
on the validity and/or reliability of relevant questions/
questionnaires/scales. Standardized methodology18 
was used to perform a review of each risk factor. We 
searched three electronic databases (PubMed, 
EMBASE, and CINAHL) in 2014–2015 using a vali-
dated measurement properties search strategy.19 
Quality assessment was completed using the 
COnsensus-based Standards for the selection of 
health Measurement Instruments (COSMIN) 
checklist.20,21
A Delphi study22,23 was then conducted to select and 
define a set of core variables for each risk factor. A 
working group (WG) of 11 researchers from Canada, 
the United States, the United Kingdom, the 
Netherlands, and Italy was assembled, including epi-
demiologists, pediatric MS neurologists, adult MS 
neurologists, and content experts. The WG included 
nine researchers actively involved in MS research 
who are also IPMSSG members. We also invited three 
content experts, selected from among authors identi-
fied through the measurement property reviews. The 
WG was divided into three sub-groups, one for each 
risk factor, with some overlapping membership and 
six members in each group. Prior to the start of the 
Delphi study, the WG met for a 2-day face-to-face 
meeting during which background knowledge to 
facilitate participation was provided.
The Delphi study had four rounds that were devel-
oped with knowledge gained from the measurement 
property systematic reviews. Delphi rounds 1, 2, and 
4 were completed anonymously online and round 3 
was face-to-face. In round 1, a research question for 
each risk factor was defined and a set of criteria were 
selected to guide selection of core variables. In 
round 2, the WG was presented with a list of broad 
areas that were relevant for each risk factor, for 
which various variables could be defined. For exam-
ple, for summer sun exposure, potential variables 
include duration of sun exposure, frequency of sun 
exposure, sun exposure during certain periods of the 
day, and so on.
We initially planned for all rounds to be online; how-
ever, because selection of core variables proved to be 
a complex process, in round 3 the WG actively 
engaged in guided discussions during a 2-day face-to-
face meeting. Given the goal was to limit the number 
of core variables, the WG also defined a set of ancil-
lary variables—variables that provide important sup-
plementary information about exposure, but were not 
deemed core. In round 4, the WG gave approval for 
the proposed Tool-Kit variables. Each Tool-Kit vari-
able includes a variable description, harmonizable 
response options, and data coding.
We also evaluated the content validity of the core 
variables using the COSMIN checklist.20,21 Each WG 
member independently rated (highly relevant, some-
what relevant, not relevant) whether the core varia-
bles (1) refer to relevant aspects of the construct being 
measured, (2) are relevant for the target study popula-
tion (e.g. age, sex, disease characteristics, country, 
setting), (3) are relevant for the purpose of the meas-
urement instrument (e.g. predicting exposure), and 
(4) together comprehensively reflect the construct 
being measured. Variables that were rated as relevant 
(highly or somewhat) remained as core variables, and 
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those that were rated as “not relevant” were subse-
quently classified as ancillary variables.
Age epochs were also defined. Differences in the 
potential for exposure based on the child’s main activ-
ities and changes in activities that represent potential 
changes in exposure were considered; but we also 
wanted to select a small number of age epochs to 
ensure questionnaires were not too long.
Results
Forty-two risk factors previously implicated in MS 
risk were identified, among 88 publications (of 1400 
records), subsequently reduced to 12 risk factors that 
are relevant for pediatric populations: body size or 
body mass index, environmental tobacco smoke 
(ETS), head injury or traumatic brain injury, history 
of infectious mononucleosis, penicillin use, physical 
activity, prenatal and perinatal factors, sibling expo-
sure and attending daycare, stressful life events, sun 
exposure, vaccinations, and vitamin D intake. Forty-
eight IPMSSG members completed the survey (35% 
response). When the responses “a priority” and 
“important” were combined, sun exposure (96%), 
vitamin D intake (94%), and ETS (93%) were most 
highly endorsed (Figure 1).
Among the reviews of measurement property studies, 
we identified 152 publications on ETS questionnaires, 
35 on sun exposure, and 13 on vitamin D intake. For 
vitamin D intake, we also searched country-specific 
food composition databases and government reports 
to identify country-specific food sources of vitamin 
D. Much of the extant measurement property litera-
ture focused on questionnaires that measure current or 
recent exposure; however, we did not find validated 
questionnaires to assess long-term exposure histories, 
as required in case-control studies. This is a major gap 
we identified in the measurement properties 
literature.
A research question for each risk factor is presented in 
Table 1 and the eight variable selection criteria in 
Table 2. In the final Tool-Kit, there are six core and 
three ancillary variables to measure ETS, six core 
and six ancillary variables to measure sun exposure, 
and six core and five ancillary variables to measure 
vitamin D intake (Table 3). An example of a sun expo-
sure core variable is provided in Table 4. The Tool-Kit 
variables can be accessed online (www.maelstrom-
research.org/mica/network/tool-kit). Our preliminary 
assessment suggests that the Tool-Kit core variables 
have good content validity.
The following age epochs were selected: (1) baby 
(birth–1 year), (2) toddler/preschool (2–4 years), (3) 
child/primary or elementary school age (5–12 years), 
and (4) teenager/high school age (13–18 years). In 
utero was also identified as an important epoch; how-
ever, given the need to modify variable definitions to 
focus on mother’s activities/behaviors, it was not 
included at this time.
Discussion
We developed the Pediatric MS Tool-Kit, which is a 
novel contribution to the field of pediatric MS 
Figure 1. Results of the Risk Factor Survey, indicating the percentage of respondents who rated each risk factor as (1) a 
priority for future research and either (2) a priority for future research or important, but not a priority for future research.
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etiological research. The Tool-Kit aims to enhance the 
methodological rigor of newly developed PoMS etio-
logic studies by proposing a measurement framework to 
facilitate the design of study-specific questionnaires. 
The short-term goals of the Tool-Kit are to enhance 
exposure measurement in individual PoMS studies, by 
proposing a set of rigorously selected and defined vari-
ables that measure priority risk factors, and to enhance 
comparability of study results, by proposing the use of a 
common measurement framework. The long-term goal 
of the Tool-Kit is to enhance the potential for collabora-
tion through data sharing and consequently larger sam-
ple sizes in harmonized analyses. The Tool-Kit provides 
a set of core and ancillary variables that are intended to 
be used to measure children’s ETS exposure, sun expo-
sure, and intake of vitamin D. The core variables are 
those that were selected for harmonized analyses. As 
the WG proposed a number of important variables to 
comprehensively measure exposure, these additional 
variables are provided as ancillary variables. The Tool-
Kit will reduce the time and resources required to design 
study-specific questionnaires.
Researchers can use the information in the Tool-Kit to 
create a questionnaire that is specific to their target 
population. The exact questions, however, are not 
provided in the Tool-Kit. We chose to provide infor-
mation about the variable to develop the questions, 
rather than exact wording of individual questions. 
This approach is referred to as flexible prospective 
harmonization.24 While the use of flexible prospective 
harmonization may hamper comparability among 
studies, it may be more appropriate for etiological 
research given study investigators are most knowl-
edgeable about their study context and target popula-
tion. In addition, flexible prospective harmonization 
will enable relevant data collected in existing PoMS 
studies to be harmonized with data collected in new 
studies, which would not be possible had we employed 
a more stringent harmonization methodology.
The need for, and value of, prospective harmonization 
has been recognized by the research community and 
is demonstrated by several examples of large prospec-
tive harmonization initiatives such as the National 
Institute of Neurological Disorders and Stroke 
(NINDS) Common Data Elements (CDE),25,26 
European Prospective Investigation into Cancer and 
Nutrition (EPIC) study,27 the PhenX Toolkit,28 and 
Canadian Partnership for Tomorrow project.29 The 
NINDS has recently developed CDE for MS that 
include variables focused on demographics, clinical 
Table 2. Eight criteria for selecting the core variables to be included in the Tool-Kit.
Selection criteria
The variable is necessary to answer the research question
The variable helps to better interpret or understand the level of exposure to the risk factor
The variable is a potential confounder or effect modifier
The variable can be collected using proxy-report (i.e. parent/guardian) via self-administered and/or interview-
administered questionnaire
The variable can be collected in a valid and reliable way, given the required retrospective nature of the data collection
The level of detail that is asked to recall is reasonable given the retrospective nature, time, and resources available
The variable is of high enough prevalence in the source population to ensure sufficient statistical power
The variables and response options should be selected to enhance cross-cultural validity
Table 1. Research questions for the three risk factors that are included in the Tool-Kit.
Risk factor Research question
Environmental 
tobacco smoke
Everything else being equal, are children who have been exposed to higher levels of environmental 
tobacco smoke at increased risk of MS compared with children who have been exposed to lower 
levels of environmental tobacco smoke?
Sun exposure Everything else being equal, are children who have been exposed to lower levels of sun at 
increased risk of MS compared with children who have been exposed to higher levels of sun?
Vitamin D 
intake
Everything else being equal, are children with lower intake of vitamin D (through supplementation) 
at increased risk of MS compared with children with higher intake of vitamin D (through 
supplementation)?
MS: multiple sclerosis.
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assessments, imaging, and neuropsychology/cogni-
tion.25,26 The NINDS also used a WG model to select 
and define the MS CDE. The MS CDE also include a 
core set of variables, which they define as essential 
information applicable to any study, and have also 
defined three sets of CDE which they classify as sup-
plemental–highly recommended, supplemental, or 
exploratory.
Table 3. Tool-Kit core and ancillary variables for the three risk factors.
Core variables Ancillary variables
Environmental tobacco smoke (ETS) exposure
1. Home ETS exposure laddera
2. Childcare ETS exposure laddera
3. Frequency of smoking by the child’s mother
4. Frequency of smoking by the child’s father
5.  Frequency of smoking by others who lived with the 
child
6. Residential history
1. Evidence that previous smoker(s) lived in child’s home
2. Smoking status of close family members and/or friends
3.  Type of tobacco products consumed by individuals who 
lived with the child
Sun exposure
1. Residential history
2.  Frequency of daily outdoor activities during daylight 
Hours
3.  Duration of time outdoors on weekends during 
summer
4.  Duration of time outdoors on weekdays during 
Summer
5. Duration of time outdoors on weekdays during winter
6.  Duration of time outdoors on weekends and school 
holidays during winter
1. Frequency of travel to sunny destinations during winter
2. Skin color
3. Sun sensitivity
4. Frequency of sun protection use: sunscreen
5.  Frequency of sun protection use: wearing a shirt with 
sleeves
6.  Frequency of sun protection use: staying in the shade or 
under an umbrella
Vitamin D intake
1. Child’s use of dietary supplements
2. Frequency that the child used dietary supplements
3.  Duration of time that the child used dietary 
supplements
4.  Child’s use of dietary supplements that contain 
vitamin D
5.  Frequency that the child used dietary supplements 
that contain vitamin D
6.  Duration of time that the child used dietary 
supplements that contain vitamin D
1.  Brands of dietary supplements that were commonly 
used by the child
2.  Use of dietary supplement was recommended by a 
health care professional
3. Child’s use of cod liver oil
4. Frequency that the child’s used cod liver oil
5. Duration of time that the child used cod liver oil
aThe ETS exposure ladders incorporate sources and locations of exposure, as well as smoking rules in the home.
Table 4. Example of a core variable included in the Tool-Kit.
Table Sun exposure
Variable name Frequency of daily outdoor activities during daylight hours
Label Frequency of outdoors activities
Description  • Classifies the frequency of the child’s usual daily outdoor activities during daylight hours
 • Self-report by parent(s) or both child and parent(s)
 • Ask for all relevant age epochs
Value type Text
Missing 9999
Unit Not applicable
Category codes and labels 3: Almost always outdoors
2: More often outdoors
1: More often indoors
0: Almost always indoors
9999: Don’t know/can’t recall
S Magalhaes, B Banwell et al.
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The Tool-Kit variables can be accessed online at 
www.maelstrom-research.org/mica/network/tool-kit. 
The information presented online includes the pro-
posed Tool-Kit variables (i.e. name, type, and descrip-
tion), response options, and data coding. To be 
harmonizable, we recommend that the information 
online be used to develop individual questions to 
include in study-specific questionnaires. Ideally, at 
least one question should be developed for each vari-
able, and the question should be worded so that it 
links to the variable description. If multiple questions 
are used, it will be important to ensure the Tool-Kit 
variables can be derived from the questions used.
The proposed response options for each variable are 
meant to be used as is, although modification is pos-
sible; however, for data to be harmonizable, research-
ers should ensure the response options in the Tool-Kit 
can be generated from modified response options. For 
example, if deemed more appropriate by the study 
investigators, finer response options may be used, but 
the new response options should be collapsible into 
those provided in the Tool-Kit. We do not recommend 
that investigators exclude any of the response options 
that are proposed in the Tool-Kit, as they form the 
basis for harmonization and were developed through 
a rigorous methodological process.
In addition to retaining the response options as pro-
posed in the Tool-Kit, the age epochs should also be 
used as is in order for data to be harmonizable. 
However, unlike the response options, collapsing age 
epochs is much more methodologically difficult and 
may render the data non-harmonized. The key is to 
ensure the Tool-Kit variables and response options 
can be generated from the data collected in a study.
Once the questionnaire is developed, we recommend 
that the actual questions and their response options be 
compared to the variable descriptions and response 
options in the Tool-Kit by an individual who was not 
involved in developing the study questionnaire, and if 
the questionnaire is used in a language other than 
English, this individual should be fluent in English 
and in the language used in the questionnaire.
The Tool-Kit is a methodological resource for ques-
tionnaire design and is not a repository of data. While 
we will maintain an inventory of studies that have 
used the Tool-Kit variables, the decision to share data, 
at the time of a proposed harmonized analysis, is left 
to the discretion of the individual study investigators. 
As the long-term goal of the Tool-Kit is to provide the 
opportunity for collaboration through harmonization, 
researchers using the Tool-Kit variables will be asked 
to provide us with some basic information about their 
study (e.g. study name, sample size, variables used) to 
be displayed on the Tool-Kit webpage. To facilitate 
this process, we ask when using the Tool-Kit to 
develop a study-specific questionnaire that this publi-
cation is cited appropriately.
The main limitation, in light of the rigorous process 
used to select the core variables, is the possibility that 
the variables selected have poor measurement prop-
erties. We were unable to identify a validated ques-
tionnaire to use in a case–control study, and thus we 
used an expert consensus-seeking approach to select 
the Tool-Kit variables. The Tool-Kit has not yet been 
tested in a “real-life” research setting. While we 
show that the core variables have good content valid-
ity, continued evaluation of the measurement proper-
ties of the Tool-Kit variables will be imperative to its 
utility and success. We are open to collaborating with 
researchers wanting to use and assess the measure-
ment properties of the core variables in their specific 
research settings.
We believe the Tool-Kit will prove to be a valuable 
resource to guide pediatric MS researchers in devel-
oping study-specific questionnaires. Rigorous epide-
miological and expert consensus methods were 
utilized to develop the Tool-Kit variables and we 
engaged the pediatric MS research community to 
ensure that what we developed is relevant. We invite 
content area experts to take the opportunity to expand 
the Tool-Kit to develop additional core variables for 
the other priority MS risk factors.
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